Novel Targets for the Development of Monoclonal Antibodies for Immunotherapy)
Clinical trial NCT06842407 · RECRUITING
Trial details
- NCT number
- NCT06842407
- Sponsor
- Checkmab S.r.l.
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2023-04-01
- Primary completion
- 2026-06-30
- Enrollment
- 600
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.